Search Results - "Cazzaniga, Gianni"
-
1
High-Throughput Immunogenetics for Clinical and Research Applications in Immunohematology: Potential and Challenges
Published in The Journal of immunology (1950) (15-05-2017)“…Analysis and interpretation of Ig and TCR gene rearrangements in the conventional, low-throughput way have their limitations in terms of resolution, coverage,…”
Get full text
Journal Article -
2
Unraveling the cellular origin and clinical prognostic markers of infant B-cell acute lymphoblastic leukemia using genome-wide analysis
Published in Haematologica (Roma) (01-06-2019)“…B-cell acute lymphoblastic leukemia is the commonest childhood cancer. In infants, B-cell acute lymphoblastic leukemia remains fatal, especially in patients…”
Get full text
Journal Article -
3
Human MLL/KMT2A gene exhibits a second breakpoint cluster region for recurrent MLL–USP2 fusions
Published in Leukemia (01-09-2019)Get full text
Journal Article -
4
Absent B cells, agammaglobulinemia, and hypertrophic cardiomyopathy in folliculin-interacting protein 1 deficiency
Published in Blood (28-01-2021)“…Agammaglobulinemia is the most profound primary antibody deficiency that can occur due to an early termination of B-cell development. We here investigated 3…”
Get full text
Journal Article -
5
HDAC6 inhibition decreases leukemic stem cell expansion driven by Hedgehog hyperactivation by restoring primary ciliogenesis
Published in Pharmacological research (01-09-2022)“…Aberrant activation of the Hh pathway promotes cell proliferation and multi-drug resistance (MDR) in several cancers, including Acute Myeloid Leukemia (AML)…”
Get full text
Journal Article -
6
-
7
Relapses and treatment-related events contributed equally to poor prognosis in children with ABL-class fusion positive B-cell acute lymphoblastic leukemia treated according to AIEOP-BFM protocols
Published in Haematologica (Roma) (01-07-2020)“…ABL-class fusions other than characterize around 2-3% of precursor B-cell acute lymphoblastic leukemia. Case series indicated that patients suffering from…”
Get full text
Journal Article -
8
Clinico-biological features of 5202 patients with acute lymphoblastic leukemia enrolled in the Italian AIEOP and GIMEMA protocols and stratified in age cohorts
Published in Haematologica (Roma) (01-11-2013)“…The outcome of children and adults with acute lymphoblastic leukemia is markedly different. Since there is limited information on the distribution of…”
Get full text
Journal Article -
9
NIPBL : a new player in myeloid cell differentiation
Published in Haematologica (Roma) (01-07-2019)“…The nucleophosmin 1 gene ( ) is the most frequently mutated gene in acute myeloid leukemia. Notably, mutations are always accompanied by additional mutations…”
Get full text
Journal Article -
10
Antibody Deficiency in Patients with Biallelic KARS1 Mutations
Published in Journal of clinical immunology (01-11-2023)“…Biallelic KARS1 mutations cause KARS-related diseases, a rare syndromic condition encompassing central and peripheral nervous system impairment, heart and…”
Get full text
Journal Article -
11
Antileukemic Efficacy of BET Inhibitor in a Preclinical Mouse Model of MLL-AF4 + Infant ALL
Published in Molecular cancer therapeutics (01-08-2018)“…-rearranged acute lymphoblastic leukemia (ALL) occurring in infants is a rare but very aggressive leukemia, typically associated with a dismal prognosis…”
Get full text
Journal Article -
12
More precisely defining risk peri-HCT in pediatric ALL: pre- vs post-MRD measures, serial positivity, and risk modeling
Published in Blood advances (12-11-2019)“…Detection of minimal residual disease (MRD) pre– and post–hematopoietic cell transplantation (HCT) for pediatric acute lymphoblastic leukemia (ALL) has been…”
Get full text
Journal Article -
13
Recurrent Germline Variant in RAD21 Predisposes Children to Lymphoblastic Leukemia or Lymphoma
Published in International journal of molecular sciences (05-05-2022)“…Somatic loss of function mutations in cohesin genes are frequently associated with various cancer types, while cohesin disruption in the germline causes…”
Get full text
Journal Article -
14
P1056: NEXT GENERATION SEQUENCING IDENTIFIES SUBGROUPS OF PATIENTS WITH TRIPLE NEGATIVE/ PRIMARY THROMBOCYTOSIS WITH DIFFERENT CLINICAL OUTCOMES
Published in HemaSphere (08-08-2023)Get full text
Journal Article -
15
The Polo-Like Kinase 1 (PLK1) inhibitor NMS-P937 is effective in a new model of disseminated primary CD56+ acute monoblastic leukaemia
Published in PloS one (08-03-2013)“…CD56 is expressed in 15-20% of acute myeloid leukaemias (AML) and is associated with extramedullary diffusion, multidrug resistance and poor prognosis. We…”
Get full text
Journal Article -
16
-
17
Development Refractoriness of MLL-Rearranged Human B Cell Acute Leukemias to Reprogramming into Pluripotency
Published in Stem cell reports (11-10-2016)“…Induced pluripotent stem cells (iPSCs) are a powerful tool for disease modeling. They are routinely generated from healthy donors and patients from multiple…”
Get full text
Journal Article -
18
Strategy to prevent epitope masking in CAR.CD19+ B-cell leukemia blasts
Published in Journal for immunotherapy of cancer (01-06-2021)“…Chimeric antigen receptor T-cells (CAR T-cells) for the treatment of relapsing/refractory B-cell precursor acute lymphoblastic leukemia have led to exciting…”
Get full text
Journal Article -
19
P337: IKZF1 DELETIONS IN B‐ALL: FROM ITS GENETIC BASIS TO DIAGNOSTIC ENHANCEMENT
Published in HemaSphere (08-08-2023)Get full text
Journal Article -
20
IKZF1 Deletions with COBL Breakpoints Are Not Driven by RAG-Mediated Recombination Events in Acute Lymphoblastic Leukemia
Published in Translational oncology (01-05-2019)“…IKZF1 deletion (ΔIKZF1) is an important predictor of relapse in both childhood and adult B-cell precursor acute lymphoblastic leukemia (B-ALL). Previously, we…”
Get full text
Journal Article